An interdisciplinary study hinging on X-ray crystallography and nuclear magnetic resonance studies has examined 1000 proteins from more than 40 different human pathogens, including those responsible for plague, anthrax, salmonella, cholera, tuberculosis, leprosy, amoebic dysentery and influenza. Researchers at the …
Tag Archives: pharmaceutical
Helical light
Posted by David Bradley
on June 15, 2012
Comments Off
Researchers have known for some time of monochromatic light beams, such as Laguerre-Gauss beams, which carry orbital angular momentum also have a helical phase profile. According to Ole Steuernagel of the University of Hertfordshires Science and Technology Research Institute, UK, …
Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
Posted by Robert Slinn
on January 16, 2012
Comments Off
Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers – The pharmaceutical sector has made a big investment in targeting kinases proteins, so there are a lot of compounds and drugs out there that, although they were …
Six Slinn Picks – chemical news
Posted by Robert Slinn
on May 31, 2011
Comments Off
Team solves decades-old molecular mystery linked to blood clotting – Researchers report that they are the first to describe in atomic detail a chemical interaction that is vital to blood clotting. Hard x-rays to watch chemical reactions – Chemists can …
Making fluorine reactions stick
Posted by David Bradley
on May 10, 2011
Comments Off
Fluorine in organic chemistry is an important topic across the synthetic pharmaceutical, agrochemical and materials areas because switching out hydrogen atoms selectivity for this element allows chemists to tune the reactivity of specific groups within a given molecule. Now, chemists …
Six Slinn Picks – chemical news
Posted by Robert Slinn
on May 4, 2011
Comments Off
Rutgers Offers Hope in New Treatment for Spinal Cord Injuries – Scientists at the W.M. Keck Center for Collaborative Neuroscience at Rutgers University and Quark Pharmaceuticals, Inc. have developed a chemically synthesized siRNA molecule that allows regeneration of nerve cells. …
